Market: NASD |
Currency: USD
Address: 21 Ha’arba’a Street
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, advanced unresectable cholangiocarcinoma, prostate cancer, and nuclear radiation protection; RHB-107 (upamostat) for treating outpatients infected with SARS-CoV-2 (COVID-19 disease) and advanced unresectable cholangiocarcinoma; RHB-104 for Crohn's disease; RHB-102 (Bekinda) for the treatment of acute gastroenteritis and gastritis, irritable bowel syndrome with diarrhea, and oncology support anti-emetic; and RHB-204 for pulmonary nontuberculous mycobacteria infections caused by mycobacterium avium complex. The company was incorporated in 2009 and is headquartered in Tel Aviv, Israel.
Show more
📈 RedHill Biopharma Ltd. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
-
-
EPS Growth Range (1Y):
-
-
Net Income Growth Range (1Y):
-
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2024 |
- |
$0.040000 |
- |
2024-08-20 |
- |
Stock split |
|
Total Amount for 2024: $0.040000 |
| 2023 |
- |
$0.025000 |
- |
2023-03-23 |
- |
Stock split |
|
Total Amount for 2023: $0.025000 |
📅 Earnings & EPS History for RedHill Biopharma Ltd.
| Date | Reported EPS |
|---|
| 2023-04-28 | - |
| 2022-11-29 | -60 |
| 2022-11-07 | -20 |
| 2022-06-23 | -30 |
| 2022-03-17 | -500 |
| 2021-11-30 | -50 |
| 2021-08-26 | -600 |
| 2021-05-27 | -500 |
| 2021-03-18 | -700 |
| 2020-11-12 | -499.82 |
| 2020-08-13 | -40 |
| 2020-05-27 | -500 |
| 2020-03-04 | -300 |
| 2019-11-19 | -300 |
| 2019-07-23 | -400 |
| 2019-05-07 | -300 |
| 2019-02-26 | -300 |
| 2018-11-13 | -400 |
| 2018-08-30 | -500 |
| 2018-05-08 | -500 |
| 2018-02-22 | -500 |
| 2017-11-13 | -900 |
| 2017-07-25 | -600 |
| 2017-05-03 | -500 |
| 2017-02-23 | -600 |
📰 Related News & Research
No related articles found for "redhill biopharma".
